ClinicalTrials.govclosed
Lorlatinib as Neoadjuvant Treatment in Stage IB-IIIB ALK-rearranged Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT06682884. IPD Sharing: NO. Countries: 0. Publications: 1.
ShareScore
28/100
Overall dataset sharing score
Score breakdown
These five areas show where the dataset supports — or may limit — practical reuse.
- Stewardship
- 8
- Harmonization
- 12
- Access
- 0
- Reuse readiness
- 0
- Engagement
- 8